{"product_id":"oakstone-topics-in-mammography-9th-edition-2025","title":"Oakstone Topics in Mammography 9th Edition 2025","description":"\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003ch3\u003eOakstone Topics in Mammography 9th Edition 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 31 videos + 6 pdfs, size: 10.24 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: radiologists in academics or private practice\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eBreast cancer is one of radiology’s most common — and most litigated — diagnoses. The 9th edition of \u003cem\u003eTopics in Breast Imaging \u003c\/em\u003egoes beyond routine updates to spotlight the breakthroughs and pitfalls shaping your practice today.\u003cbr\u003e\u003cbr\u003eIn this online video course, Dr. R. James Brenner and a nationally recognized faculty from UC San Diego, Weill Cornell, City of Hope\u003csup\u003e®\u003c\/sup\u003e Cancer Center, and Mayo Clinic employ real-world cases, expert commentary, and imaging–histopathology correlations to help you sharpen interpretations, strengthen recommendations, and avoid the medico-legal missteps that cause most malpractice claims. Through 31 evidence-based continuing medical education lectures, you’ll explore:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAI \u0026amp; Liability: \u003c\/strong\u003eWhere AI truly helps, where it introduces risk, and what this means for your medico-legal exposure\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMRI Everywhere: \u003c\/strong\u003eFrom staging and recurrence detection to diffusion applications and incidental findings\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiopsy vs. Surveillance: \u003c\/strong\u003eWhen “watchful waiting” is safer than intervention\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpecial Circumstances\u003c\/strong\u003e: Pregnancy-associated breast cancer and imaging for transgender patients\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e September 15, 2025\u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cem\u003eAt the conclusion of this activity, you will be able to:\u003c\/em\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDifferentiate the imaging findings of benign and malignant breast masses\u003c\/li\u003e\n\u003cli\u003eRecognize the features of benign or malignant calcifications on mammogram\u003c\/li\u003e\n\u003cli\u003eFormulate approaches to one- and two-view asymmetries seen on screening mammogram\u003c\/li\u003e\n\u003cli\u003eRecognize the issues regarding and methods to detect sentinel lymph nodes of the breast\u003c\/li\u003e\n\u003cli\u003eEvaluate the issues regarding risk, breast density and phenotypes, mathematical models\u003c\/li\u003e\n\u003cli\u003eAnalyze the different approaches to supplementary screening imaging modalities beyond mammography\u003c\/li\u003e\n\u003cli\u003eRecognize the indications and limitations of stereotactic breast biopsy\u003c\/li\u003e\n\u003cli\u003eAnalyze different approaches and limitations of ultrasound guided breast techniques\u003c\/li\u003e\n\u003cli\u003eCompare different methods of preoperative image-guided localization of nonpalpable lesions for surgical excision\u003c\/li\u003e\n\u003cli\u003eReview technique issues for biopsy using nuclear imaging, MRI imaging, contrast-enhanced (CEM) imaging\u003c\/li\u003e\n\u003cli\u003eDecide on appropriate management recommendations following percutaneous breast biopsies of “high risk” lesions\u003c\/li\u003e\n\u003cli\u003eDistinguish the criteria and conditions for recommending surveillance imaging as opposed to biopsy for probably benign breast lesions identified on imaging\u003c\/li\u003e\n\u003cli\u003eRecognize the signs of silicone implant rupture\u003c\/li\u003e\n\u003cli\u003eAnalyze the indications and outcome expectations of applied criteria for interpreting MRI studies\u003c\/li\u003e\n\u003cli\u003eRecognize current molecular profiles assigned to breast cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eDiscuss the histologic basis for macroscopic findings on mammography\u003c\/li\u003e\n\u003cli\u003eExplain the potentials and limitations of incorporating artificial intelligence (AI) into breast imaging practice\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\n\u003cbr\u003eThis course is intended for radiologists in academics or private practice, and involved in breast imaging and interventional procedures. Any physician (e.g. surgeons) working in the field of evaluation and treatment of breast disease who desires a more comprehensive understanding of the imaging aspects of evaluation.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch3\u003ePractical Approaches to Mammographic Interpretation\u003c\/h3\u003e\n\u003cbr\u003eHistopathology of Breast Disease – A Radiologist’s Guide – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eSentinel Node Evaluation – What the Radiologist Needs to Know – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eAsymmetries Initially Seen in One (or Two) Views at Screening – How to Dismiss or Localize Them – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eEvaluation of Breast Masses and Architectural Distortion – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eBreast Calcifications – The Good, the Bad, the Ugly – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\n\u003cbr\u003e\u003ch3\u003eScreening for Breast Cancer: Imaging Parameters for Different Modalities\u003c\/h3\u003e\n\u003cbr\u003ePhysics of FFDM, DBT, and CEM – \u003cem\u003eDavid Hall, PhD, DABR\u003cbr\u003e\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMammographic Screening for Breast Cancer – Evidence and Analysis – \u003cem\u003eMohammad Eghtedari, MD\u003cbr\u003e\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eBreast Density and Phenotypes Issues of Risk Management – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eSupplementary Breast Screening – Whole Breast Ultrasound – Contrast Enhanced Mammography (CEM); Nuclear Techniques MRI; Other (Coned Beam CT, Spiral CT, Phase Sensitive Tomosynthesis) – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eOther Supplementary Screening Techniques Beyond Ultrasound – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003ePregnancy Associated Breast Cancer – Clinical Presentation, Diagnostic Challenges, and Management Considerations – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eBreast Imaging of Transgender Individuals – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\n\u003cbr\u003e\u003ch3\u003eBreast Lesion Management: Surveillance and Interventional Techniques\u003c\/h3\u003e\n\u003cbr\u003eCurrent Status and Future of BI-RADS – The Next Edition – \u003cem\u003eHaydee Ojeda-Fournier, MD, FACR, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eBiopsy Techniques and Pre-Op Localization Part 1 – Stereotactic Bx – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eBiopsy Techniques and Pre-Op Localization Part 2 – Ultrasound Guided Bx and Perioperative Localization – \u003cem\u003eMohammad Eghtedari, MD, PhD\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eCEM-Guided Breast Biopsy – \u003cem\u003eChristopher Comstock, MD, FACR, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMolecular Breast Imaging Guided Biopsy – \u003cem\u003eKatie Hunt, MD\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMRI Guided Breast Biopsies – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eControversies in Management Following Percutaneous Breast Biopsy – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eSurveillance Breast Imaging – Initial Surveillance of Lesion Instead of Biopsy Surveillance of PTS with Cancer and Non-Surgical DCIS – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\n\u003cbr\u003e\u003ch3\u003eMRI\u003c\/h3\u003e\n\u003cbr\u003eMagnetic Resonance Imaging Breast: Silicone Evaluation – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMagnetic Resonance Imaging Breast: Tumor Studies – General Approaches and Analysis of Mass and Non-Mass Lesions; Unknown Primary – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMagnetic Resonance Imaging Breast: Tumor Studies – Staging of Breast Cancer; Resection, Recurrence, and Lymph Node Analysis – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMagnetic Resonance Imaging Breast: Tumor Studies – Surveillance, Neoadjuvant Rx, Problem Solving: False Positive and False Negative Studies – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMagnetic Resonance Imaging Breast: Tumor Studies – Incidental Findings at MRI Actionable and Non-Actionable – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\n\u003cbr\u003e\u003ch3\u003eMedical Legal Aspects of Breast Imaging\u003c\/h3\u003e\n\u003cbr\u003eMedical Legal Issues in Breast Imaging – Overview of Legal Landscape Issues of Detection and Diagnosis – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMedical Legal Issues in Breast Imaging – Issues with DBT, AI Triaging, and AI Impact on Triaging – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMedical Legal Issues of Breast Imaging – Preventable Causes of Falst Negative Breast Imaging Studies – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eMedical Legal Issues of Breast Imaging – Issues in Communication – Substance of Report, Timeliness of Report, Credibility of Report, and Nature of the Communication – \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM, FSBI\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003eAn Overview of AI in Breast Imaging\u003cem\u003e – Tara Retson, MD\u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954503192674,"sku":"MED-AMB04809","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Oakstone-Topics-in-Mammography-9th-Edition-2025.jpg?v=1779378289","url":"https:\/\/meducourse.com\/products\/oakstone-topics-in-mammography-9th-edition-2025","provider":"Meducourse","version":"1.0","type":"link"}